Table 2.
Amount of patients (% of 1370)
|
||
---|---|---|
Endoxifen ≥ 5.97 ng/mL | Endoxifen <5.97 ng/mL | |
AAS ≥ 1798 | 1083 (79.1) | 48 (3.5) |
AAS < 1798 | 24 (1.7) | 215 (15.7) |
AAS Antiestrogenic Activity Score; 5.97 ng/mL
Amount of patients (% of 1370)
|
||
---|---|---|
Endoxifen ≥ 5.97 ng/mL | Endoxifen <5.97 ng/mL | |
AAS ≥ 1798 | 1083 (79.1) | 48 (3.5) |
AAS < 1798 | 24 (1.7) | 215 (15.7) |
AAS Antiestrogenic Activity Score; 5.97 ng/mL